首页> 中文期刊> 《中国医学创新》 >胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗及长期缓解的临床研究*

胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗及长期缓解的临床研究*

         

摘要

Objective:To observe the effect of insulin pump intensive therapy inβcell function of different body mass index in patients with type 2 diabetes,insulin resistance and long-term remission. Method:Patients with type 2 diabetes in our hospital were divided into two groups according to body mass index:the obesity group and normal group. All patients were treated with insulin pump intensive treatment. 2 weeks before and after treatment, 18 months after treatment,theβcell function and insulin resistance were taken for analysis. Result:The HOMA-β,HOMA-IR in the obesity group before and after treatment in patients were significantly higher than those in the normal group(P<0.05).After 2 weeks of treatment,two groups of patients with HOMA-β,HOMA-IR and efficacy compared to baseline values were significantly decreased(P<0.05);follow-up results after 18 months, patients in the two group,HOMA-βHOMA-IR and efficacy compared to baseline values were significantly decreased(P<0.05).Conclusion:Insulin pump therapy in the treatment of different body mass index in patients has the improving function with newly diagnosed type 2 diabetes isletβcell function, insulin resistance,also has the effect of long-term remission.%  目的:观察胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗的影响。方法:将本院收诊的2型糖尿病患者按体重指数分成两组,肥胖组和正常组。所有患者均采用胰岛素泵进行强化治疗,分别于治疗前、治疗2周后、治疗18个月后对胰岛β细胞功能、胰岛素抵抗进行分析。结果:肥胖组患者治疗前后HOMA-β、HOMA-IR均显著高于正常组(P<0.05);治疗2周后,两组患者的HOMA-β、HOMA-IR与疗效基线值相比均显著下降(P<0.05);18个月后随访结果发现,两组患者的HOMA-β、HOMA-IR与疗效基线值相比仍显著下降(P<0.05)。结论:胰岛素泵强化治疗对不同体重指数初诊2型糖尿病胰岛β细胞功能、胰岛素抵抗均有改善作用,而且具有长期缓解作用。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号